This article is more than 5 years old. Information may no longer be current.
Macular translocation shows promise in patients with CNV
Click Here to Manage Email Alerts
SANTIAGO, Chile — Macular translocation with 360º retinotomy can stabilize and in some cases improve visual acuity in patients with subfoveal choroidal neovascularization caused by age-related macular degeneration, according to a surgeon speaking here.
At the Pan-American Congress of Ophthalmology, José Asilis Mera, MD, presented results of this surgical technique in seven consecutive patients, all between 56 and 85 years old. In all patients, the translocation was carried out successfully, Dr. Asilis Mera said.
At 6 months postoperatively, three of the seven patients demonstrated improved near visual acuity, with near VA of 20/200 or better, and two patients demonstrated stabilized near VA. Two patients lost three or more lines of Snellen acuity, leading Dr. Asilis Mera to caution that patients who start out with good vision should be handled with extreme care.
Dr. Asilis Mera said he and his colleagues believe that this technique can be a promising therapeutic option, in that it appeared to stabilize or improve vision in most cases. He said one weakness of his study was that there was no control group. The indications for the use of macular translocation in patients with CNV are not well defined, and more study is necessary, he said.